Quick Answer
BioXcel Therapeutics, Inc. reported Common Stock Shares Outstanding of 22.33 million shares for the year ending 2025.
- BioXcel Therapeutics, Inc. showed an increase of +619.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BioXcel Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), BioXcel Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 125.4%.
- Historical annual values: Fiscal year 2025: 22.33 million shares | Fiscal year 2024: 3.10 million shares | Fiscal year 2023: 1.87 million shares | Fiscal year 2022: 28.15 million shares | Fiscal year 2021: 27.98 million shares | Fiscal year 2020: 24.42 million shares | Fiscal year 2019: 18.09 million shares | Fiscal year 2018: 15.66 million shares | Fiscal year 2017: 9.91 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: